Optimizing bioconversion pathways through systems analysis and metabolic engineering.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 11854482.
- Also identified by PMC identifier 122274.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We demonstrate a general approach for metabolic engineering of biocatalytic systems comprising the uses of a chemostat for strain improvement and radioisotopic tracers for the quantification of pathway fluxes. Flux determination allows the identification of target pathways for modification as validated by subsequent overexpression of the corresponding gene. We demonstrate this method in the indene bioconversion network of Rhodococcus modified for the overproduction of 1,2-indandiol, a key precursor for the AIDS drug Crixivan.
Medical subject headings
- Biomedical Engineering
- Drug Industry